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THE authors have previously isolated and purified ursolic
acid from heather flowers (Calluna vulgarts). This
terpene was found to inhibit HL-60 leukaemic cell prolif-
eration and arachidonic acid oxidative metabolism in
various cell species. The effects of ursolic acid and its
analogues on soybean 15-lipoxygenase activity and on
the proliferation of a human gastric tumour cell line
(HGT), have been assessed. These triterpenes inhibited
soybean 15-lipoxygenase at its optimal activity (pH 9).
The proliferation ofHGTwas decreased in a dose-depend-
ent manner. At 20tM the rank order is: ursolic
acid > uvaol > oleanolic acid > methyl ursolate. The
carboxylic group at the C2s position of ursolic acid ap-
pears to be implicated in the inhibition of both
lipoxygenase activity and cell proliferation. Thus
methylation of this group decreases these two inhibitory
properties. Oleanolic acid, which differs by the position
ofone methyl group (C20 instead of C19) is less inhibitory
than ursolic acid. The lipophilicity of the terpene is also
implicated since uvaol appears to be more inhibitory
than methyl ursolate.
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Introduction
Arachidonic acid can be oxygenated by two dis-
tinct pathways, cyclooxygenase and lipoxygenase,
which differ not only in their products but also in
their susceptibility to regulation by biological and
pharmacological agents. Additionally, a third path-
way for arachidonic acid oxygenation, via NADPH-
dependent cytochrome P-450 monooxygenases
(epoxygenases), has been described recently in vari-
ous tissues and cells. The lipoxygenase pathway
converts arachidonic acid to a family of hydroxy
(peroxy)eicosatetraenoic acids (H(P)ETEs) and to a
series of more complex metabolites termed leuko-
trienes, lipoxines and hepoxylines. The functional
properties of the lipoxygenase products have not
been elucidated completely. However, it is clear that
the lipoxygenase pathway generates the release of
extracellular lipid mediators of inflammation such as
leukotrienes B (LTB4) EWe4, LTD and EWE4 .3 Several
studies have suggested a role for intracellular media-
tors in the formation of lipoxygenase products. 4,5
In an effort to search for new anti-inflammatory
and/or new anti-proliferative natural compounds,
the authors have used the inhibition test of these
enzymes to screen several heather flower extracts of
Calluna vulgaris. This plant is mainly used in folk
medicine as extracts, especially in the treatment of
inflammatory diseases. An aqueous extract of
() 1994 Rapid Communications of Oxford Ltd
Calluna vulgaris (eVE) shows inhibition specifically
of arachidonate 5-1ipoxygenase and potent anti-pro-
liferative effects on human leukaemia HL-60 cells. In
acetone-eVE, ursolic acid has been shown as the
agent responsible for inhibition of lipoxygenase ac-
tivity. Ursolic acid was found to be an inhibitor of
both potato tuber 5-1ipoxygenase and soybean 15-
lipoxygenase. Ursolic acid also inhibits arachidonic
acid metabolism in platelets, mouse peritoneal mac-
rophages and differentiated HL-60 leukaemic cells.
Subsequently, the X-ray crystallographic structure of
the molecule was determined and it was shown that
the compound adopts a chair conformation.1
In this paper the effects of ursolic acid and its
analogues (uvaol, oleanolic acid and methyl
ursolate) on both lipoxygenase activity and prolifera-
tion of a human gastric tumour cell line (HGT)n were
studied in order to obtain more information on the
chemical reactions of ursolic acid that are implicated
in its pharmacological action.
Materials and Methods
Chemicals: Ursolic acid was either obtained from
Sigma or isolated from Calluna vulgaris as described
previously. Uvaol and oleanolic acid were obtained
from Sigma. Methyl ursolate was prepared by
methylation of ursolic acid with diazomethane.2
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Lipoxygenase assay: The standard assay mixture con-
tained the enzyme soybean 15-1ipoxygenase (from
Sigma) and the reaction was started by addition of
linoleic acid (Sigma). Inhibition experiments were
carried out by measuring the loss of activity of 15-
lipoxygenase (0.11/.tM) in the presence of various
concentrations of triterpene. Lipoxygenase activity
was determined spectrophotometrically by monitor-
ing the absorbance at 234 nm of 13-(S)-hydroperoxy-
cis-9-trans-ll-octadecadienoic acid (13(S)-HPODE)
(Emax 25 000M-1cill-1) formed from linoleic acid
(71 M), at 20C in 1 ml of 0.2 M borate buffer (pH 9).
Cell culture: HGT cells at a concentration of 2 x 105
were grown (in triplicate) in 6-well culture plates
(Nunc) in 2ml of Dulbecco’s modified Eagle’s
medium (Gibco) supplemented with 10% heat inac-
tivated foetal calf serum (Gibco), penicillin (100 U/
ml) and streptomycin (100/.tg/ml) (Gibco) at 37C in
a humidified atmosphere containing 5% CO2 in air.
Drug solutions were added to cultures at day 1. At
24 h intervals, the viability of cells was determined as
described below.
Growth experiments: Ursolic acid and its analogues
were dissolved in DMSO (Merck). Stock solutions
were prepared at 10 mM and stored at 4C. Control
culture received the same quantity of DMSO only.
Cell counts and viable cells were assessed by trypan
blue exclusion.
MTT assay: The MTT colorimetric assay was carried
out as described initially by Mosmann. 13 This test is
based upon the selective ability of living cells to re-
duce the yellow soluble salt, MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide)
(Sigma), to a purple-blue insoluble formazan pre-
cipitate. Experiments were performed in triplicate in
6-well culture plates (Nunc). MTT was dissolved in
phosphate buffered saline (PBS) at 5 mg/ml. After
24 h incubation ofHGT cells with ursolic acid and its
analogues, stock MTT solution (200/.tl per 2ml
medium) was added and plates were incubated at
37C for 4 h. Then sodium dodecyl sulphate (SDS)
(10% in HCl, 0.01 M) was added and the amount of
coloured formazan metabolite formed was deter-
mined by absorbance at 550-690 nm.
Plating efficiency: Cells were plated into wells con-
taining 2 ml of growth medium alone or in the
presence of drugs (20 btM). After 24 h, cells were
washed with HBSS and were removed from wells
with 0.5 ml of trypsin/EDTA (Gibco). Adherent cells
were counted using a haemocytometer.
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FIG. 1. Formulae of ursolic acid and analogues.
are shown in Fig. 1. The effects of the four com-
pounds on soybean 15-1ipoxygenase activity are
shown in Fig. 2. The best inhibitors of soybean 15-
lipoxygenase activity were ursolic acid and oleanolic
acid, with a IC50 values of 0.175 mM and 0.265 mM,
respectively.
All the tested drugs (1 to 30 btM) had no effect on
cell viability after 1 h and 6 h of incubation. Table 1
shows that ursolic acid has more effect on plating
efficiency than does either uvaol or oleanolic acid. In
contrast, its methyl ester had no effect on plating
efficiency.
Figure 3 shows the dose-dependent inhibitory ef-
fect of ursolic acid and its analogues after 5 days of
HGT cell proliferation. Proliferation ofHGT cells was
decreased by ursolic acid, with an IC50 of 20/.tM. In
contrast, uvaol, oleanolic acid and methyl ursolate
had no significant effect. Figure 4 shows the time-
dependent inhibition of HGT cell proliferation using
20/.tM ursolic acid and its analogues. Although
ursolic acid exhibits a marked inhibitory effect,
methyl ursolate is almost devoid of effect.
Results
The chemical structures of ursolic acid and its
analogues uvaol, oleanolic acid and methyl ursolate
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Discussion
Lipoxygenase dependent growth has been re-
ported for various malignant cell lines such asEffects of ursolic acid on I5-1ipoxygenase activity
20
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FIG. 2. Effects of ursolic acid and analogues on in vitro soybean 15-
lipoxygenase activity (pH 9). Results are expressed in % of residual activ-
ity. [], ursolic acid;, oleanolic acid; x,), methyl ursolate; , uvaol.
Table 1. Percentage of plating efficiency of HGT cells in the
presence of ursolic acid and its analogues. Values are
averages + S.D. from two independent experiments, each done in
triplicate (n 6)
Additions to media Plating efficiency (%)
None 90 + 10
Ursolic acid (20 pM) 11.7 + 8.3
Uvaol (20 IM) 45.6 + 7.3
Oleanolic acid (20 IM) 85.5 + 6.5
Methyl ursolate (20 IM) 92.1 + 8
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FIG. 3. Concentration-dependent inhibition of proliferation of HGT cells by
ursolic acid and analogues, after 5 days of the growth. Results represent
the mean of three independent experiments in triplicate. S.D. is always less
than 5% in all cases. El, ursolic acid; I, uvaol;, oleanolic acid;,
methyl ursolate.
neuroblastoma,
14 mouse melanoma15 and MCF-7
human breast cancer cells. 16 Previous data have
reported that the lipoxygenase inhibitor BW 755C
suppressed the proliferation of HGT cells in a
concentration dependent manner. 17 The authors have
4
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FIG. 4. Time-dependent inhibition of proliferation of HGT cells by ursolic
acid and its analogues, at 201M. Results represent the mean of two
independent experiments in triplicate. S.D. is always less than 5% in all
cases. , ursolic acid;, uvaol; I!, oleanolic acid; F], control; ,
methyl ursolate.
studied the effects of ursolic acid and its analogues
on the proliferation of HGT cells and on the in vitro
activity of soybean 15-1ipoxygenase.
Results of the in vitro soybean 15-1ipoxygenase
assay show that the carboxylic group at position of
C28 ursolic acid is implicated in the inhibition of both
lipoxygenase activity and cell proliferation. Methyl-
ation of this group eliminates these two inhibitory
properties. The structural character of ursolic acid is
also important for its inhibitory effects, since
oleanolic acid, which differs from ursolic acid only in
the position of one methyl group (at C20 instead
of C19) is less inhibitory than ursolic acid. HGT
cell proliferation is less sensitive to ursolic acid
(IC50 20 l.tM) than is HL-60 proliferation. Previous
data reported that ursolic acid inhibited HL-60 DNA
synthesis with an IC50 value of 1 btM.
Ursolic acid exhibits an effect on HGT cell prolif-
eration at concentrations which do not directly
inhibit 15-1ipoxygenase activity. Furthermore, olea-
nolic acid, which inhibits soybean 15-1ipoxygenase
with an IC50 of 0.265 mM, has only a small effect at
20 btM on HGT cell proliferation. Together, these data
suggest that ursolic acid may act at this concentration
(20 l.tM) by additional mechanisms other than just
direct lipoxygenase inhibition. Another hypothesis is
that the effect on tumour cells is a more sensitive test
than the assay for lipoxygenase inhibition. Finally,
the lipophilicity of the terpenes is also implicated in
the effect of ursolic acid since uvaol is more inhibi-
tory than methyl ursolate; this latter compound being
more lipophilic than uvaol.
Ursolic acid probably acts on physical and func-
tional properties of cell membranes and may be an
additional class of membrane active agents with
potential anti-cancer activity. It may be a pleiotropic
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membrane active agent that seeps into the lipidic
layers and affects multiple signal transduction path-
ways in mammalian cells. Clearly further experiments
need to be performed to clarify these points.
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